What is the appropriate evaluation and management for suspected viral labyrinthitis in a patient with sudden right‑sided echo‑like tinnitus, vertigo, no earwax, and recent viral upper‑respiratory infection?

Viral Labyrinthitis: Evaluation and Management

For a patient with sudden-onset tinnitus, vertigo, and recent viral URI, you should obtain urgent audiometry to confirm sensorineural hearing loss, then offer systemic corticosteroids within 2 weeks of symptom onset, as this presentation represents sudden sensorineural hearing loss (SSNHL) with vestibular involvement—whether labeled "viral labyrinthitis" or "SSNHL with vertigo," the treatment approach is identical.

Diagnostic Approach

Immediate Evaluation

The clinical presentation of sudden unilateral tinnitus and vertigo following viral URI requires audiometry within 14 days of symptom onset to confirm SSNHL 1. The 2019 AAO-HNS guideline emphasizes that routine labs and head CT are not recommended 1. Your physical exam should specifically assess for:

• Bilateral versus unilateral hearing loss (bilateral suggests systemic etiology)
• Focal neurologic deficits (suggests central pathology requiring different workup)
• Conductive versus sensorineural loss (Weber and Rinne tests, though audiometry is definitive) 1

Recent case reports confirm that even when MRI is obtained, it may be normal despite clinically significant labyrinthitis 2, so imaging should not delay treatment.

Risk Stratification

Patients with vertigo at onset have poorer prognosis for hearing recovery 1. This is critical for counseling—your patient's vertigo suggests they fall into this higher-risk category.

Treatment Algorithm

First-Line Therapy (Within 2 Weeks)

Offer systemic corticosteroids immediately 1. The guideline notes this as an "option" based on RCT evidence, but given the profound QOL impact of permanent hearing loss and the favorable risk-benefit profile, this should be standard practice. Typical regimen: oral prednisone 1 mg/kg/day (max 60 mg) for 10-14 days with taper.

Do NOT prescribe antivirals—the guideline explicitly states "insufficient evidence to support their effectiveness" despite common practice 1. While some recent case reports mention empiric acyclovir use 2, the highest-quality guideline evidence recommends against routine antiviral therapy 1.

Symptomatic Management

• Vestibular suppressants (meclizine, dimenhydrinate) for acute vertigo—use short-term only (3-5 days) as prolonged use delays central compensation
• Antiemetics as needed for nausea
• Vestibular rehabilitation therapy once acute phase resolves 3, 4

Salvage Therapy (2-6 Weeks Post-Onset)

If hearing recovery is incomplete at 2-6 weeks, offer intratympanic steroid injections 1. This is a firm recommendation from the guideline for salvage therapy.

Imaging Considerations

Order MRI of brain and internal auditory canals (or auditory brainstem response if MRI contraindicated) to screen for vestibular schwannoma 1. This doesn't need to be emergent but should be completed during the evaluation period. The guideline clarifies this workup is for retrocochlear pathology, not to diagnose labyrinthitis itself 1.

Do not order routine head CT—this is a strong recommendation against 1. CT has no role unless you suspect temporal bone pathology or need to rule out stroke (which would present with central signs).

Follow-Up Protocol

• Repeat audiometry at conclusion of treatment and within 6 months 1
• Counsel about audiologic rehabilitation if residual hearing loss persists—this includes hearing aids, cochlear implant evaluation for profound loss, and tinnitus management strategies 1
• Monitor for psychological sequelae (anxiety, depression, social isolation) which are common 1

Prognostic Counseling

Be direct about expectations: One-third to two-thirds may recover spontaneously within 2 weeks 1. However, patients with vertigo (like yours) have worse prognosis 1. Those showing minimal improvement in first 2 weeks are unlikely to achieve significant recovery 1. This honest discussion is mandated by the guideline 1.

Common Pitfalls

• Delaying audiometry: Waiting beyond 14 days reduces diagnostic accuracy and delays treatment
• Prescribing antivirals: No evidence supports this despite historical practice
• Ordering routine labs or head CT: Wastes resources without improving outcomes 1
• Failing to offer salvage therapy: Many patients eligible for intratympanic steroids never receive them
• Inadequate counseling: Patients need realistic expectations about recovery and rehabilitation options